---
title: "Enliven Therapeutics falls 6%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305340621.md"
description: "Enliven Therapeutics fell 6.00% to US$48.12. Up 14.02% over six months and up 213.18% YTD."
datetime: "2026-11-12T15:13:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305340621.md)
  - [en](https://longbridge.com/en/news/305340621.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305340621.md)
generator: "portal-rs"
---

# Enliven Therapeutics falls 6%

Enliven Therapeutics (ELVN.US) fell more than **6%** during regular trading to **$48.12**.

The stock is up 7.68% over the past five sessions, up 14.02% over the past six months and up 213.18% year to date. It sits 22.79% below its 52-week high of US$62.32.

The Nasdaq Composite is up 3.97% over the past five sessions and up 8.77% year to date.

The company reported zero revenue for the third quarter of fiscal 2026, with its net loss widening due to increased research and development expenses.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ELVN.US](https://longbridge.com/en/quote/ELVN.US.md)

## Related News & Research

- [Enliven Therapeutics Chief Medical Officer Helen Louise Collins reports sale of $234,203.1101 in common shares](https://longbridge.com/en/news/306180389.md)
- [ELVN: Second-line-plus phase III launch is imminent, with a potential early-2029 readout](https://longbridge.com/en/news/305860981.md)
- [Jabil (JBL) Heads Into Earnings As Its AI Narrative Keeps Undervalued View Alive](https://longbridge.com/en/news/306391907.md)
- [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md)
- [Kevin O’Leary declared 'inflation affects all of us' while shopping for Walmart paper towel bargains. How to fight back](https://longbridge.com/en/news/306393334.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**